Vaccines, Blood and Biologics

Sentinel is used by the U.S. FDA’s Center for Biologics Evaluation and Research (CBER) to assess the safety of vaccines, blood products, and other biological products, including cellular, tissue, and gene therapies. Information about CBER and how it makes use of Sentinel in its postmarket safety surveillance programs can be found in the About CBER section. 

Assessments of vaccines, blood products, and other biologics are posted publicly in this section and are available for download. A complete listing of these assessments can be accessed through an Assessment Database that is searchable by medical product name, health outcome of interest, and study type.